Clinical Experience With a Multidisciplinary Model of Vascular Ultrasound for the Evaluation for Giant Cell Arteritis

por Tedeschi, Sara K., Sobiesczyzk, Piotr S., Ford, Julia A., DiIorio, Michael A., Docken, William P.
Publicado 2021

LIN-12/Notch Regulates GABA Signaling at the Caenorhabditis elegans Neuromuscular Junction

por Sorkaç, Altar, DiIorio, Michael A., O’Hern, Patrick J., Baskoylu, Saba N., Graham, Hannah K., Hart, Anne C.
Publicado 2018

Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy

por Vanni, Kathleen MM, Patel, Naomi J, DiIorio, Michael, Kowalski, Emily, Qian, Grace, Cook, Claire E, Ritter, Susan Y, Wallace, Zachary S, Sparks, Jeffrey A
Publicado 2022

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study

por Patel, Naomi J., D’Silva, Kristin M., Hsu, Tiffany Y-T., DiIorio, Michael, Fu, Xiaoqing, Cook, Claire, Prisco, Lauren, Martin, Lily, Vanni, Kathleen M.M., Zaccardelli, Alessandra, Zhang, Yuqing, Sparks, Jeffrey A., Wallace, Zachary S.
Publicado 2021

Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study

por Patel, Naomi J., D'Silva, Kristin M., Hsu, Tiffany Y‐T., DiIorio, Michael, Fu, Xiaoqing, Cook, Claire, Prisco, Lauren, Martin, Lily, Vanni, Kathleen M. M., Zaccardelli, Alessandra, Zhang, Yuqing, Sparks, Jeffrey A., Wallace, Zachary S.
Publicado 2021

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron

por Kawano, Yumeko, Patel, Naomi J., Wang, Xiaosong, Cook, Claire E., Vanni, Kathleen M.M., Kowalski, Emily N., Banasiak, Emily P., Qian, Grace, DiIorio, Michael, Hsu, Tiffany Y. T., Weinblatt, Michael E., Todd, Derrick J., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2022

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study

por Di Iorio, Michael, Cook, Claire E., Vanni, Kathleen M.M., Patel, Naomi J., D’Silva, Kristin M., Fu, Xiaoqing, Wang, Jiaqi, Prisco, Lauren C., Kowalski, Emily, Zaccardelli, Alessandra, Martin, Lily W., Qian, Grace, Hsu, Tiffany Y-T., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2022

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study

por Di Iorio, Michael, Cook, Claire E., Vanni, Kathleen M.M., Patel, Naomi J., D'Silva, Kristin M., Fu, Xiaoqing, Wang, Jiaqi, Prisco, Lauren C., Kowalski, Emily, Zaccardelli, Alessandra, Martin, Lily W., Qian, Grace, Hsu, Tiffany Y-T., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2022

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

por DiIorio, Michael, Kennedy, Kevin, Liew, Jean W, Putman, Michael S, Sirotich, Emily, Sattui, Sebastian E, Foster, Gary, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Moni, Tarin T, Thabane, Lehana, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Gore-Massy, Monique, Howard, Richard A, Kodhek, More A, Lalonde, Nadine, Tomasella, Laura-Ann, Wallace, John, Akpabio, Akpabio, Alpízar-Rodríguez, Deshiré, Beesley, Richard P, Berenbaum, Francis, Bulina, Inita, Chock, Eugenia Yupei, Conway, Richard, Duarte-García, Alí, Duff, Eimear, Gheita, Tamer A, Graef, Elizabeth R, Hsieh, Evelyn, El Kibbi, Lina, Liew, David FL, Lo, Chieh, Nudel, Michal, Singh, Aman Dev, Singh, Jasvinder A, Singh, Namrata, Ugarte-Gil, Manuel F, Hausmann, Jonathan S, Simard, Julia F, Sparks, Jeffrey A
Publicado 2022